Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
about
Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Emerging technologies in the delivery of erythropoietin for therapeutics.New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design.
P2860
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@ast
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@en
type
label
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@ast
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@en
prefLabel
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@ast
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@en
P2093
P2860
P356
P1476
Careful adjustment of Epo non-viral gene therapy for beta-thalassemic anaemia treatment.
@en
P2093
Daniel Scherman
Emmanuel Payen
Emmanuelle E Fabre
Pascal Bigey
Yves Beuzard
P2860
P2888
P356
10.1186/1479-0556-6-10
P577
2008-03-11T00:00:00Z
P5875
P6179
1018018880